GlassScriptPhysician profile
Jennifer P Beller
NPI 1629280896
$1,220.43
in general payments reported to CMS, 2019-2025
18 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $78.62 · 2021: $74.29 · 2022: $77.17 · 2023: $192 · 2024: $284 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $644.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $294.82 | 2019-2025 | Evenity |
| Novo Nordisk INC | $202.93 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Beta Bionics, INC. | $102.61 | 2024 | Ilet Bionic Pancreas |
| Lilly USA, LLC | $101.13 | 2022-2024 | Jardiance, Zepbound, Mounjaro |
| Dexcom, INC. | $98.67 | 2019-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $80.86 | 2022-2024 | Omnipod |
| Sanofi-Aventis U.S. LLC | $68.49 | 2019-2023 | |
| Abbvie INC. | $47.07 | 2021-2023 | Synthroid |
| Senseonics, Incorporated | $31.00 | 2019 | |
| Ascendis Pharma Endocrinology INC | $29.27 | 2025 | Yorvipath |
| Xeris Pharmaceuticals, INC. | $24.58 | 2022 | |
| Shire North American Group INC | $24.22 | 2019 | |
| Abbott Laboratories | $23.05 | 2024 | Freestyle Libre 3 |
| Tandem Diabetes Care, INC. | $21.46 | 2020 | |
| Recordati_rare_diseases_inc. | $20.89 | 2023 | Signifor Lar, Isturisa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sequel Med Tech, LLC | $18.02 | 2025 | Twiist |
| Pfizer INC. | $16.49 | 2019 | |
| Mannkind Corporation | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Beller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.